FORM OF INCENTIVE STOCK OPTION GRANT AGREEMENT CORBUS PHARMACEUTICALS HOLDINGS, INC.Incentive Stock Option Grant Agreement • May 20th, 2024 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
FORM OF Restricted Stock Agreement CORBUS PHARMACEUTICALS HOLDINGS, INC.Restricted Stock Agreement • May 20th, 2024 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Award Agreement (the “Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A (the “Award Date”), is entered into between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).
FORM OF NONQUALIFIED STOCK OPTION GRANT AGREEMENT CORBUS PHARMACEUTICALS HOLDINGS, INC.Stock Option Grant Agreement • May 20th, 2024 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT CORBUS PHARMACEUTICALS HOLDINGS, INC. 2024 EQUITY INCENTIVE PLANRestricted Stock Unit Award Agreement • May 20th, 2024 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Restricted Stock Unit Award Agreement (the “Agreement” or “Award Agreement”), dated as of the “Award Date” set forth in the attached Exhibit A, is entered into between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Awardee”).
